Due to a production error, there was an error in affiliation 1. Instead of “Department of Dermatology, Hospital of Jilin University, Changchun, China”, it should be “Department of Dermatology, First Hospital of Jilin University, Changchun, China”.
The publisher apologizes for this mistake. The original version of this article has been updated.
Summary
Keywords
COVID-19, SARS-CoV-2, psoriasis, comorbidity, management, biologics
Citation
Frontiers Production Office (2024) Erratum: Psoriasis comorbidity management in the COVID era: a pressing challenge. Front. Microbiol. 15:1502059. doi: 10.3389/fmicb.2024.1502059
Received
26 September 2024
Accepted
26 September 2024
Published
04 October 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
15 - 2024
Updates
Copyright
© 2024 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.